153 related articles for article (PubMed ID: 34167636)
1. Nano-Aromatic Drugs Based on Mesoporous Silica Nanoparticles and Bergamot Essential Oil for Anti-Depression.
Yang XH; Peng H; Hao QL; Wang JZ; Lu ZG; Niu YW; Xiao ZB; Zhang X
J Biomed Nanotechnol; 2021 Jun; 17(6):1242-1248. PubMed ID: 34167636
[TBL] [Abstract][Full Text] [Related]
2. Extra-Large Pore Mesoporous Silica Nanoparticles for Directing in Vivo M2 Macrophage Polarization by Delivering IL-4.
Kwon D; Cha BG; Cho Y; Min J; Park EB; Kang SJ; Kim J
Nano Lett; 2017 May; 17(5):2747-2756. PubMed ID: 28422506
[TBL] [Abstract][Full Text] [Related]
3. Cinnamon Oil Encapsulated with Silica Nanoparticles: Chemical Characterization and Evaluation of Insecticidal Activity Against the Rice Moth, Corcyra cephalonica.
Attia RG; Khalil MMH; Hussein MA; Fattah HMA; Rizk SA; Ma'moun SAM
Neotrop Entomol; 2023 Jun; 52(3):500-511. PubMed ID: 36913124
[TBL] [Abstract][Full Text] [Related]
4. Requirements for Translation in Clinical Trials of Aromatherapy: The Case of the Essential Oil of Bergamot (BEO) for Management of Agitation in Severe Dementia.
Scuteri D; Sakurada S; Sakurada T; Tonin P; Bagetta G; Nicotera P; Corasaniti MT
Curr Pharm Des; 2022; 28(20):1607-1610. PubMed ID: 35579159
[TBL] [Abstract][Full Text] [Related]
5. Antinociceptive effect of inhalation of the essential oil of bergamot in mice.
Scuteri D; Crudo M; Rombolà L; Watanabe C; Mizoguchi H; Sakurada S; Sakurada T; Greco R; Corasaniti MT; Morrone LA; Bagetta G
Fitoterapia; 2018 Sep; 129():20-24. PubMed ID: 29906556
[TBL] [Abstract][Full Text] [Related]
6. A prominent anchoring effect on the kinetic control of drug release from mesoporous silica nanoparticles (MSNs).
Tran VA; Lee SW
J Colloid Interface Sci; 2018 Jan; 510():345-356. PubMed ID: 28961433
[TBL] [Abstract][Full Text] [Related]
7. A pH-responsive nano-carrier with mesoporous silica nanoparticles cores and poly(acrylic acid) shell-layers: fabrication, characterization and properties for controlled release of salidroside.
Peng H; Dong R; Wang S; Zhang Z; Luo M; Bai C; Zhao Q; Li J; Chen L; Xiong H
Int J Pharm; 2013 Mar; 446(1-2):153-9. PubMed ID: 23395877
[TBL] [Abstract][Full Text] [Related]
8. Peptide-laden mesoporous silica nanoparticles with promoted bioactivity and osteo-differentiation ability for bone tissue engineering.
Luo Z; Deng Y; Zhang R; Wang M; Bai Y; Zhao Q; Lyu Y; Wei J; Wei S
Colloids Surf B Biointerfaces; 2015 Jul; 131():73-82. PubMed ID: 25969416
[TBL] [Abstract][Full Text] [Related]
9. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
Li T; Geng T; Md A; Banerjee P; Wang B
Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
[TBL] [Abstract][Full Text] [Related]
10. Construction of selenium-embedded mesoporous silica with improved antibacterial activity.
Chen J; Wei Y; Yang X; Ni S; Hong F; Ni S
Colloids Surf B Biointerfaces; 2020 Jun; 190():110910. PubMed ID: 32126358
[TBL] [Abstract][Full Text] [Related]
11. Mesoporous Silica Nanoparticles with Large Pores for the Encapsulation and Release of Proteins.
Tu J; Boyle AL; Friedrich H; Bomans PH; Bussmann J; Sommerdijk NA; Jiskoot W; Kros A
ACS Appl Mater Interfaces; 2016 Nov; 8(47):32211-32219. PubMed ID: 27933855
[TBL] [Abstract][Full Text] [Related]
12. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery.
Li Z; Zhang Y; Feng N
Expert Opin Drug Deliv; 2019 Mar; 16(3):219-237. PubMed ID: 30686075
[TBL] [Abstract][Full Text] [Related]
13. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
[TBL] [Abstract][Full Text] [Related]
14. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan.
Zhang Y; Zhi Z; Jiang T; Zhang J; Wang Z; Wang S
J Control Release; 2010 Aug; 145(3):257-63. PubMed ID: 20450945
[TBL] [Abstract][Full Text] [Related]
15. Hybrid mesoporous silica nanospheres modified by poly (NIPAM-co-AA) for drug delivery.
Zhang K; Zhou D; Wang Z; Zhang Y; He P
Nanotechnology; 2019 Aug; 30(35):355604. PubMed ID: 31071691
[TBL] [Abstract][Full Text] [Related]
16. Successfully tailoring the pore size of mesoporous silica nanoparticles: exploitation of delivery systems for poorly water-soluble drugs.
Jia L; Shen J; Li Z; Zhang D; Zhang Q; Duan C; Liu G; Zheng D; Liu Y; Tian X
Int J Pharm; 2012 Dec; 439(1-2):81-91. PubMed ID: 23078857
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.
Lee JE; Lee N; Kim T; Kim J; Hyeon T
Acc Chem Res; 2011 Oct; 44(10):893-902. PubMed ID: 21848274
[TBL] [Abstract][Full Text] [Related]
18. Microfluidic preparation of PLGA composite microspheres with mesoporous silica nanoparticles for finely manipulated drug release.
Zhou J; Zhai Y; Xu J; Zhou T; Cen L
Int J Pharm; 2021 Jan; 593():120173. PubMed ID: 33321168
[TBL] [Abstract][Full Text] [Related]
19. Mesoporous silica nanoparticles for therapeutic/diagnostic applications.
Jafari S; Derakhshankhah H; Alaei L; Fattahi A; Varnamkhasti BS; Saboury AA
Biomed Pharmacother; 2019 Jan; 109():1100-1111. PubMed ID: 30551360
[TBL] [Abstract][Full Text] [Related]
20. Licorice isoliquiritigenin-encapsulated mesoporous silica nanoparticles for osteoclast inhibition and bone loss prevention.
Sun X; Zhang J; Wang Z; Liu B; Zhu S; Zhu L; Peng B
Theranostics; 2019; 9(18):5183-5199. PubMed ID: 31410209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
